Discontinued — last reported Q4 '21
Nasdaq, Inc. Short-Term Borrowings remained flat by 0.0% to $431.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 7.8%, from $400.00M to $431.00M. Over 5 years (FY 2020 to FY 2025), Short-Term Borrowings shows a downward trend with a -6.3% CAGR. This is a positive signal — lower values indicate better performance for this metric.
High levels may indicate a reliance on short-term credit markets for operational cash flow, which can increase liquidity risk.
Short-term borrowings consist of debt obligations that are due within one year, excluding the current portion of long-te...
Varies by industry; pharmaceutical firms often maintain access to short-term credit for operational flexibility.
short_term_borrowings| Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q4 '23 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $1.02B | $1.10B | $1.02B | $799.00M | $664.00M | $788.00M | $548.00M | $499.00M | $399.00M | $400.00M | $500.00M | $431.00M | $431.00M | $431.00M |
| QoQ Change | — | +7.9% | -7.1% | -21.7% | -16.9% | +18.7% | -30.5% | -8.9% | -20.0% | +0.3% | +25.0% | -13.8% | +0.0% | +0.0% |
| YoY Change | — | — | — | — | -34.8% | +18.7% | — | — | -49.4% | — | -8.8% | -13.6% | +8.0% | +7.8% |